Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 89 citing articles:

Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 456
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 95
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 61
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism
Jing Zhang, Yongya Wu, Yanhong Li, et al.
Phytomedicine (2024) Vol. 129, pp. 155600-155600
Open Access | Times Cited: 20
2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis
Peng Fu, Minru Liao, Wenke Jin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 35
Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy
Qitong Wu, Dipali Sharma
Cells (2023) Vol. 12, Iss. 8, pp. 1156-1156
Open Access | Times Cited: 30
Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer
Yanmei Chen, Wei Xu, Yang Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 8, pp. 2531-2550
Open Access | Times Cited: 30
CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy
Xinli Liu, Ge Zhang, Tongyao Yu, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126147-126147
Closed Access | Times Cited: 24
Ferroptosis: the emerging player in remodeling triple-negative breast cancer
Jie Li, Dejiao He, Sicheng Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Types of Cell Death from a Molecular Perspective
Fatemeh Hajibabaie, Navid Abedpoor, Parisa Mohamadynejad
Biology (2023) Vol. 12, Iss. 11, pp. 1426-1426
Open Access | Times Cited: 23
RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
Zhi Xu, Xiumei Wang, Wenbo Sun, et al.
Redox Biology (2023) Vol. 68, pp. 102952-102952
Open Access | Times Cited: 22
The crosstalk between oncogenic signaling and ferroptosis in cancer
Qianghu Pang, Zhirou Tang, Lianxiang Luo
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104349-104349
Closed Access | Times Cited: 7
Tumor Vascular Normalization by B7-H3 Blockade Augments T Lymphocyte-Mediated Antitumor Immunity
Xin Dai, Boran Cao, Xinnan Liu, et al.
European Journal of Pharmacology (2025), pp. 177334-177334
Closed Access
Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy‐dependent cell death, and necroptosis
Yuanyuan Yang, Yanmei Chen, Jun Hao Wu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1488-1525
Closed Access | Times Cited: 18
Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer
Yang Xu, Li Deng, Xiaopeng Diao, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108218-108218
Open Access | Times Cited: 18
Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It
Cong Chen, Qianwei Ye, Linbo Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Ferroptosis, autophagy, tumor and immunity
Yuyan Xie, Yang Zhou, Jiale Wang, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19799-e19799
Open Access | Times Cited: 17
Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy
Shutong Li, Aoxue Wang, Yongya Wu, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 300-334
Closed Access | Times Cited: 16
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 6
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top